Guggenheim Stays Bullish on Cigna (CI) With Updated $318 Price Target

Image by Alexsander-777 from Pixabay

On December 2, Guggenheim lifted the firm’s terms people connected The Cigna Group (NYSE:CI) to $318 from $309 and maintained a Buy standing connected the stock.

In its net for the 3rd 4th of 2025, The Cigna Group (NYSE:CI) announced that it is addressing immoderate of the biggest challenges successful the healthcare industry, and for that, the institution unveiled a caller pharmacy payment exemplary that eliminates rebates, with outgo reductions and accrued transparency, portion helping section pharmacies. Overall, Cigna Group reported a 10% YoY maturation successful its revenues astatine $69.7 cardinal successful Q3. The gross besides bushed analysts’ estimates by $3 billion.

The Cigna Group (NYSE:CI)’s Evernorth Health Services, which includes Pharmacy Benefit Services and Specialty and Care Services operating segments, was the main contributor to the gross growth. The segment’s adjusted gross and adjusted income from operations grew by 15% and 1%, respectively.

The Cigna Group (NYSE:CI) is an American multinational managed healthcare and security institution that offers a wide scope of related services and products.

While we admit the imaginable of CI arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Blue Chip Dividend Stocks to Build a Passive Income Portfolio and 15 Dividend Stocks That Outperform the S&P 500.

Disclosure: None.